Pruritus Therapeutics Market By Product (Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, Pipeline, Unmet Needs), By Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria) Analysis And Segment Forecasts To 2025

Report ID: 978-1-68038-365-2
Number of Pages: 78
Format: Electronic (PDF)

Historical Data: 2012-2014
Industry: Healthcare

Market segmentation

Global Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
- Corticosteroids
- Antihistamines
- Local Anesthetics
- Counterirritants
- Immunosuppressant
- Calcineurin Inhibitors
- Others
Global Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
- Atopic Dermatitis
- Allergic Contact Dermatitis
- Urticaria
- Others
Pruritus Therapeutics Regional Outlook (Revenue, USD Million, 2012 - 2025)
- North America
  - U.S.
    - U.S. Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
      - Corticosteroids
      - Antihistamines
      - Local Anesthetics
      - Counterirritants
      - Immunosuppressant
      - Calcineurin Inhibitors
      - Others
- Rest of North America
  - Rest of North America Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
    - Corticosteroids
    - Antihistamines
    - Local Anesthetics
    - Counterirritants
    - Immunosuppressant
    - Calcineurin Inhibitors
    - Others
  - Rest of North America Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
    - Atopic Dermatitis
    - Allergic Contact Dermatitis
    - Urticaria
    - Others

Europe
- Germany
  - Germany Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
    - Corticosteroids
    - Antihistamines
    - Local Anesthetics
    - Counterirritants
    - Immunosuppressant
    - Calcineurin Inhibitors
    - Others
  - Germany Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
    - Atopic Dermatitis
    - Allergic Contact Dermatitis
    - Urticaria
    - Others
- UK
  - UK Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
    - Corticosteroids
    - Antihistamines
    - Local Anesthetics
    - Counterirritants
    - Immunosuppressant
    - Calcineurin Inhibitors
    - Others
  - UK Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
    - Atopic Dermatitis
    - Allergic Contact Dermatitis
    - Urticaria
    - Others
- France
  - France Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
    - Corticosteroids
    - Antihistamines
    - Local Anesthetics
    - Counterirritants
    - Immunosuppressant
    - Calcineurin Inhibitors
    - Others
  - France Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
    - Atopic Dermatitis
    - Allergic Contact Dermatitis
    - Urticaria
    - Others
- Italy
  - Italy Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
    - Corticosteroids
    - Antihistamines
    - Local Anesthetics
    - Counterirritants
    - Immunosuppressant
    - Calcineurin Inhibitors
    - Others
  - Italy Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
    - Atopic Dermatitis
    - Allergic Contact Dermatitis
    - Urticaria
    - Others
- Spain
  - Spain Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
    - Corticosteroids
    - Antihistamines
    - Local Anesthetics
    - Counterirritants
    - Immunosuppressant
    - Calcineurin Inhibitors
    - Others
  - Spain Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
    - Atopic Dermatitis
    - Allergic Contact Dermatitis
    - Urticaria
    - Others
- Rest of Europe
  - Rest of Europe Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
    - Corticosteroids
    - Antihistamines
    - Local Anesthetics
    - Counterirritants
    - Immunosuppressant
    - Calcineurin Inhibitors
    - Others
  - Rest of Europe Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
    - Atopic Dermatitis
    - Allergic Contact Dermatitis
    - Urticaria
    - Others
Asia Pacific
- Japan
  - Japan Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
    - Corticosteroids
    - Antihistamines
    - Local Anesthetics
    - Counterirritants
    - Immunosuppressant
    - Calcineurin Inhibitors
    - Others
  - Japan Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
    - Atopic Dermatitis
    - Allergic Contact Dermatitis
    - Urticaria
    - Others
- Rest of Asia Pacific
  - Rest of Asia Pacific Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
    - Corticosteroids
    - Antihistamines
    - Local Anesthetics
    - Counterirritants
    - Immunosuppressant
    - Calcineurin Inhibitors
    - Others
  - Rest of Asia Pacific Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
    - Atopic Dermatitis
    - Allergic Contact Dermatitis
    - Urticaria
    - Others
RoW
- RoW Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
  - Corticosteroids
  - Antihistamines
  - Local Anesthetics
  - Counterirritants
  - Immunosuppressant
  - Calcineurin Inhibitors
  - Others
- RoW Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
  - Atopic Dermatitis
  - Allergic Contact Dermatitis
  - Urticaria
  - Others

Report Content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2012 to 2025
Revenue estimates for product up to 2025
Regional market size and forecast for product up to 2025
Revenue estimates for disease type up to 2025
Regional market size and forecast for disease type up to 2020
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.